Search research articles
Contact Us
Filters
Showing results (71-80 of 122) with videos related to
Page
of 13
Sort By:
Clinical Trials (London, England)
|
August 24, 2007
Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board
Janet Wittes, Elizabeth Barrett-Connor, Eugene Braunwald, et al.
The New England Journal of Medicine
|
December 28, 2022
Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease. Reply
Finnian R Mc Causland, Ajay K Singh, Brian L Claggett, et al.
American Heart Journal
|
October 12, 2010
Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease
Harvey White, Claes Held, Ralph Stewart, et al.
Journal of Cardiac Failure
|
October 14, 2014
Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl
Melanie P Chin, Danielle Wrolstad, George L Bakris, et al.
Therapeutic Innovation & Regulatory Science
|
September 21, 2018
Responsibilities of Data Monitoring Committees: Consensus Recommendations
Barbara E Bierer, Rebecca Li, Jonathan Seltzer, et al.
The New England Journal of Medicine
|
June 25, 2011
Bardoxolone methyl and kidney function in CKD with type 2 diabetes
Pablo E Pergola, Philip Raskin, Robert D Toto, et al.
Ophthalmology
|
April 18, 2016
Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT): A Phase 3 Randomized Controlled Trial
Timothy L Jackson, Riti Desai, Andrew Simpson, et al.
The New England Journal of Medicine
|
September 1, 2025
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension
John M Flack, Michel Azizi, Jenifer M Brown, et al.
Circulation
|
September 1, 2006
Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas
Scott D Solomon, Marc A Pfeffer, John J V McMurray, et al.
Clinical Trials (London, England)
|
February 25, 2016
The treatment of missing data in a large cardiovascular clinical outcomes study
Roderick J Little, Julia Wang, Xiang Sun, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 122) with videos related to
Sort By:
Page
of 13
Clinical Trials (London, England)
|
August 24, 2007
Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board
Janet Wittes, Elizabeth Barrett-Connor, Eugene Braunwald, et al.
The New England Journal of Medicine
|
December 28, 2022
Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease. Reply
Finnian R Mc Causland, Ajay K Singh, Brian L Claggett, et al.
American Heart Journal
|
October 12, 2010
Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease
Harvey White, Claes Held, Ralph Stewart, et al.
Journal of Cardiac Failure
|
October 14, 2014
Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl
Melanie P Chin, Danielle Wrolstad, George L Bakris, et al.
Therapeutic Innovation & Regulatory Science
|
September 21, 2018
Responsibilities of Data Monitoring Committees: Consensus Recommendations
Barbara E Bierer, Rebecca Li, Jonathan Seltzer, et al.
The New England Journal of Medicine
|
June 25, 2011
Bardoxolone methyl and kidney function in CKD with type 2 diabetes
Pablo E Pergola, Philip Raskin, Robert D Toto, et al.
Ophthalmology
|
April 18, 2016
Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT): A Phase 3 Randomized Controlled Trial
Timothy L Jackson, Riti Desai, Andrew Simpson, et al.
The New England Journal of Medicine
|
September 1, 2025
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension
John M Flack, Michel Azizi, Jenifer M Brown, et al.
Circulation
|
September 1, 2006
Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas
Scott D Solomon, Marc A Pfeffer, John J V McMurray, et al.
Clinical Trials (London, England)
|
February 25, 2016
The treatment of missing data in a large cardiovascular clinical outcomes study
Roderick J Little, Julia Wang, Xiang Sun, et al.
Page
of 13